Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Eupraxia Pharmaceuticals Stock News

EPRXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$3.29

-0.70-17.54%

After Hours: Mar 31, 5:45 PM EDT

Eupraxia Pharmaceuticals (EPRX) Forecast

News

Earnings Eupraxia Pharmaceuticals (EPRX) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest Eupraxia Pharmaceuticals Stock News | NASDAQ:EPRX | Benzinga

Get the latest news on Eupraxia Pharmaceuticals stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Eupraxia Pharmaceuticals performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Thursday, March 20, 2025

Eupraxia Pharmaceuticals Q4 Net Profit $(7.5)...
Benzinga Newsdesk - Mar 20, 2025, 5:47PM

Tuesday, February 25, 2025

Eupraxia Pharmaceuticals shares are trading h...
Benzinga Newsdesk - Feb 25, 2025, 9:17AM
Eupraxia's EP-104GI Demonstrates Strong Safet...
Benzinga Newsdesk - Feb 25, 2025, 7:51AM

Tuesday, February 18, 2025

Eupraxia Pharmaceuticals CFO Bruce Cousins To...
Benzinga Newsdesk - Feb 18, 2025, 7:20AM

Wednesday, November 20, 2024

Eupraxia Pharmaceuticals shares are trading h...
Benzinga Newsdesk - Nov 20, 2024, 10:39AM
Eupraxia Pharmaceuticals Unveiled New Pharmac...
Benzinga Newsdesk - Nov 20, 2024, 7:16AM

Thursday, November 14, 2024

Rodman & Renshaw Initiates Coverage On Euprax...
Benzinga Newsdesk - Nov 14, 2024, 7:01AM

Tuesday, November 12, 2024

Eupraxia Reports Additional Clinical Data Fro...
Benzinga Newsdesk - Nov 12, 2024, 6:00PM

Thursday, November 07, 2024

Eupraxia Pharmaceuticals Reports Q3 Net Incom...
Benzinga Newsdesk - Nov 7, 2024, 5:40PM
Eurpaxia Pharmaceuticals Q3 EPS $(0.17) Up Fr...
Benzinga Newsdesk - Nov 7, 2024, 5:34PM

Tuesday, October 15, 2024

Eupraxia Pharamceuticals shares are trading h...
Benzinga Newsdesk - Oct 15, 2024, 9:21AM
Eupraxia Recently Publishes Phase 2 Data From...
Benzinga Newsdesk - Oct 15, 2024, 7:41AM

Wednesday, September 11, 2024

Eupraxia Pharmaceuticals Announced Additional...
Benzinga Newsdesk - Sep 11, 2024, 7:08AM

Wednesday, August 07, 2024

Eupraxia Pharmaceuticals Q2 EPS $(0.17) Vs $(...
Benzinga Newsdesk - Aug 7, 2024, 5:44PM

Wednesday, June 05, 2024

Eupraxia Pharmaceuticals To Present Results F...
Benzinga Newsdesk - Jun 5, 2024, 7:28AM

Thursday, May 23, 2024

Eupraxia Says Regulators In Australia And Can...
Benzinga Newsdesk - May 23, 2024, 5:23PM

Wednesday, May 22, 2024

Why Urban Outfitters Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
Avi Kapoor - May 22, 2024, 8:16AM
Eupraxia Pharmaceuticals shares are trading h...
Benzinga Newsdesk - May 22, 2024, 6:41AM

Tuesday, May 21, 2024

Eupraxia Pharmaceuticals shares are trading h...
Benzinga Newsdesk - May 21, 2024, 5:05PM
Eupraxia Pharmaceuticals Announces Additional...
Benzinga Newsdesk - May 21, 2024, 5:02PM

Thursday, April 11, 2024

Eupraxia Reports Upcoming Presentations At Os...
Benzinga Newsdesk - Apr 11, 2024, 7:13AM

Monday, April 08, 2024

Why Esperion Therapeutics Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
Avi Kapoor - Apr 8, 2024, 5:15AM

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved